DAX
±0,00
%
Gold
±0,00
%
BörsenNEWS.de
Home
Börse
Märkte
Trends
Aktien
Indizes
Rohstoffe
Crypto
Derivate
Analyse
Niedrigstes KGV
Beste Dividende
Marktkapitalisierung
Meistgehandelt
Beste Performance
Termine
Handelskalender
Verfallstage
Community
Foren Übersicht
Meistdiskutiert
Community
News
Aktien
Indizes
Rohstoffe
Fonds
Anleihen
Zertifikate
Optionsscheine
Devisen
Crypto
News
Schlagzeilen
Nachrichten
Community
Meldungen
DAX-News
Dow Jones-News
MDAX-News
Märkte
Aktien
Indizes
Rohstoffe
Devisen
Partner
Archiv
KI-Fragen
Suche
Suche
BörsenNEWS.de
Home
Suche
Suche
Sofort finden was Sie suchen
Alles
News
Aktie
Aktie
Achieve Life Sciences
A2QAR3 / US0044685008
4,28
EUR
+0,06
%
News
GNW-Adhoc: US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) - the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives
News
EQS-News: Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca
News
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
News
INFICON Achieves Record Results in Fourth Quarter and Fiscal Year 2023
News
CONSOLIDATED UNAUDITED FINANCIAL RESULTS FOR THE SIX-MONTH PERIOD ENDED 30 SEPTEMBER 2023
News
Syngenta Group announces Mary-Dell Chilton awarded National Medal of Technology and Innovation
News
EQS-News: ‘From out of this world, to first in the world’: Element Lab Solutions helps the Open University to purchase the first Syft Tracer™, furthering the study of space science in the UK
News
Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
News
EQS-News: BIO-Europe Set to Break Records in Munich, Germany
News
M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials
News
GNW-Adhoc: US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) - the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives
News
EQS-News: Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca
News
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
News
INFICON Achieves Record Results in Fourth Quarter and Fiscal Year 2023
News
CONSOLIDATED UNAUDITED FINANCIAL RESULTS FOR THE SIX-MONTH PERIOD ENDED 30 SEPTEMBER 2023
News
Syngenta Group announces Mary-Dell Chilton awarded National Medal of Technology and Innovation
News
EQS-News: ‘From out of this world, to first in the world’: Element Lab Solutions helps the Open University to purchase the first Syft Tracer™, furthering the study of space science in the UK
News
Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
News
EQS-News: BIO-Europe Set to Break Records in Munich, Germany
News
M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials
Aktie
Achieve Life Sciences
A2QAR3 / US0044685008
4,28
EUR
+0,06
%
Anmelden
Login
Neu hier?
Jetzt Registrieren
Passwort vergessen?
weiter